Wednesday, 13. May 2020 | Filed under Company News

Company News: Mikrogen erhält CE-Zertifizierung für Antikörpertest zum Nachweis von SARS-CoV-2 / COVID-19

– German only –

— Test kompatibel mit üblichen Laborautomaten (ELISA-Systemen)

— Herstellung von 1.600.000 Testkits pro Monat möglich

— Lösung erlaubt erstmals zuverlässige, kostengünstige und flächendeckende Testung

Mikrogen GmbH, ein Unternehmen, das gentechnisch hergestellte in vitro Diagnostika entwickelt, hat heute die CE-Kennzeichnung seines recomWell SARS-CoV-2 IgG-Tests bekannt gegeben.

Read more…

Monday, 11. May 2020 | Filed under Company News

Company News: TolerogenixX Reports Positive Phase Ib Data of its Lead Product to Combat Transplant Rejection

– Product shows excellent safety and tolerability

– Enables long-term reduction of standard medications and side effects while maintaining immune tolerance and transplant function

– Findings endorsed by third-party experts

TolerogenixX GmbH, a biopharmaceutical company developing personalized, cellular therapies to combat organ rejection and autoimmune diseases, today announced the publication of positive Phase Ib results of its lead product MIC-Lx in The Journal of Clinical Investigation ( Read more…

Tuesday, 31. March 2020 | Filed under Company News

Company News: BellaSeno Appoints Dr. Mohit Chhaya as Chief Executive Officer

– Former CEO Dr. Simon Champ to become a member of BellaSeno´s Supervisory Board

BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced that co-founder and former Chief Technology Officer Dr. Mohit Chhaya, PhD, has been appointed as the Company´s Chief Executive Officer. Starting on April 1, 2020, he will take over duties from BellaSeno´s current CEO and co-founder Dr. Simon Champ, MBA. Simon Champ will become a member of BellaSeno’s Supervisory Board.

Read more…